[Edaily Reporter KYUNG GYEYOUNG ] CANALI, an Italian luxury men’s lifestyle brand officially imported by Shinwon(009270), announced on the 3rd that it opened a flagship store on the 6th floor of The Estate at the Shinsegae Co.,Ltd Main Store in Jung-gu, Seoul, at the end of last month.
This marks CANALI’s fourth official store, following locations at HYUNDAIDEPARTMENTSTORECO.,LTD’s Apgujeong Main Store, Galleria Department Store in Apgujeong, and the HotelShilla.
The CANALI store, which opened on the 6th floor of The Estate at the Shinsegae Co.,Ltd Main Store in Jung-gu, Seoul, at the end of last month. (Photo: Shinwon)
The newly opened CANALI boutique harmoniously blends Italian modern elegance with understated design, carefully selected materials, and CANALI’s unique craftsmanship, creating a warm yet sophisticated atmosphere. The seasonal collection is prominently displayed at the center of the store, allowing customers to experience the Italian luxury lifestyle and the brand’s philosophy at a glance.
Along with this, Canali also unveiled its Fall/Winter (FW) 2026 collection. This collection offers a modern reinterpretation of Canali’s signature elegance and embodies the value of “Made in Italy” based on the brand’s philosophy of craftsmanship and attention to detail.
The Canali store at Shinsegae Co.,Ltd’s Main Branch offers a VIP program that includes “Me by Canali,” a Made-to-Measure (MTM) service.
A Shinwon official stated, “The Shinsegae Co.,Ltd Main Store is truly Korea’s largest shopping mecca, attracting not only domestic customers but also a steady influx of foreign tourists, and hosting numerous luxury brands,” adding, “We will continue to expand our distribution network in phases so that customers both in Korea and abroad can experience Canali in a variety of locations.”
A photo shoot featuring Ethan Hawke, Canali’s global ambassador. (Photo courtesy of Shinwon)
The slump in the non-investment-grade corporate bond market—which has been centered on BBB-rated bonds this year—is expected to spread to A-rated companies next year. As the burden of issuing corporat…
Amid broader market volatility on Thursday, South Korea’s biopharmaceutical sector lacked a clear directional trend, leaving traditional, profitable pharmaceutical and biotech firms to anchor investor…
A forecast indicates that U.S. production of humanoid robots will reach up to 400,000 units by 2030 and 1.5 million units by 2035. Analysts predict that as the humanoid robot industry moves beyond tec…